Marimed (MRMD) Enterprise Value (QoQ) (2012 - 2026)
Marimed (MRMD) Enterprise Value (QoQ) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | Marimed | 30.77 Mn | 22.33 Mn | 16.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -5.22% |
| Mar 31, 2026 | 8.52% |
| Dec 31, 2025 | -27.54% |
| Sep 30, 2025 | -6.11% |
| Jun 30, 2025 | 11.57% |
| Mar 31, 2025 | 0.61% |
| Dec 31, 2024 | 21.61% |
| Sep 30, 2024 | 3.22% |
| Jun 30, 2024 | 29.64% |
| Mar 31, 2024 | -3.30% |
| Dec 31, 2023 | -8.71% |
| Sep 30, 2023 | 7.72% |
| Jun 30, 2023 | 29.80% |
| Mar 31, 2023 | -104.58% |
| Dec 31, 2022 | 11.63% |
| Sep 30, 2022 | -30.07% |
| Jun 30, 2022 | 72.77% |
| Mar 31, 2022 | -15.35% |
| Dec 31, 2021 | -16.03% |
| Sep 30, 2021 | -43.83% |